← Open Payments lookup

JILL DIMARTINIS: Open Payments

NPI 1225057565 · WELLS, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$454 in 17 payments from 9 companies in 2025. Trend: 2023 $37 · 2024 $0 · 2025 $454

Food & beverage: $454
CompanyPaymentsAmount
Novo Nordisk Inc5$194
Amgen Inc.3$64
ABBVIE INC.2$62
Lilly USA, LLC2$36
AstraZeneca Pharmaceuticals LP1$23
GlaxoSmithKline, LLC.1$20
PFIZER INC.1$20
Teva Pharmaceuticals USA, Inc.1$19
Aimmune Therapeutics, Inc.1$15

Products named: Ozempic, EVENITY, VRAYLAR, MOUNJARO, BREZTRI, Wegovy, AREXVY, PAXLOVID.

Industry payments across ME — which companies pay providers there.